Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
BioCardia Inc (BCDA)
NASDAQ:BCDA
BioCardia (BCDA) Stock Price & Analysis
147 Followers
BCDA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.23 - $2.60
Previous Close$1.77
Volume58.65K
Average Volume (3M)28.96K
Market Cap
$38.03M
Enterprise Value$32.49M
Total Cash (Recent Filing)$4.86M
Total Debt (Recent Filing)$1.55M
Price to Earnings (P/E)-2.7
Beta0.57
Next Earnings
Aug 10, 2023EPS Estimate
-$0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.65
Shares Outstanding20,219,087
10 Day Avg. Volume70,533
30 Day Avg. Volume28,962
Standard Deviation0.22
R-Squared0.05
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-1.33
Price to Sales (P/S)587.62
Price to Cash Flow (P/CF)-3.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue23.96
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-6.92
Forecast
1Y Price Target
$9.00Price Target Upside402.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
BioCardia News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BCDA FAQ
What was BioCardia Inc’s price range in the past 12 months?
BioCardia Inc lowest stock price was $1.23 and its highest was $2.60 in the past 12 months.
What is BioCardia Inc’s market cap?
Currently, no data Available
When is BioCardia Inc’s upcoming earnings report date?
BioCardia Inc’s upcoming earnings report date is Aug 10, 2023 which is in 70 days.
How were BioCardia Inc’s earnings last quarter?
BioCardia Inc released its earnings results on May 10, 2023. The company reported -$0.17 earnings per share for the quarter, missing the consensus estimate of -$0.16 by -$0.01.
Is BioCardia Inc overvalued?
According to Wall Street analysts BioCardia Inc’s price is currently Undervalued.
Does BioCardia Inc pay dividends?
BioCardia Inc does not currently pay dividends.
What is BioCardia Inc’s EPS estimate?
BioCardia Inc’s EPS estimate is -$0.15.
How many shares outstanding does BioCardia Inc have?
BioCardia Inc has 20,219,088 shares outstanding.
What happened to BioCardia Inc’s price movement after its last earnings report?
BioCardia Inc reported an EPS of -$0.17 in its last earnings report, missing expectations of -$0.16. Following the earnings report the stock price went up 0.503%.
Which hedge fund is a major shareholder of BioCardia Inc?
Currently, no hedge funds are holding shares in BCDA
---
BioCardia Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.00 (402.79% Upside)
$9.00 (402.79% Upside)
Insider Transactions
Bought Shares
Worth $10.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
6.62%
12-Months-Change
Fundamentals
Return on Equity
-260.72%
Trailing 12-Months
Asset Growth
-44.49%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
BioCardia Inc
BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA.
---
Top 5 ETFs holding BCDA
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold BCDA. The ETFs are listed according to market value of BCDA within the ETF
---
Adverum Biotechnologies
―
Cidara Therapeutics
―
Eledon Pharmaceuticals
―
Eloxx Pharmaceuticals
―
---